Home-based cardiac rehabilitation versus hospital-based rehabilitation: A cost effectiveness analysis

• Published in: International journal of cardiology 2007-07, Vol.119 (2), p.196-201
• Main Authors: Taylor, R.S, Watt, A, Dalal, H.M, Evans, P.H, Campbell, J.L, Read, K.L.Q, Mourant, A.J, Wingham, Jenny, Thompson, D.R, Pereira Gray, D.J
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Cardiac rehabilitation; Cardiology. Vascular system; Cardiovascular; Coronary heart disease; Cost; Cost effectiveness; Cost-Benefit Analysis; England; Female; Health Status Indicators; Heart; Home Care Services, Hospital-Based - economics; Hospitalization - economics; Humans; Logistic Models; Male; Medical sciences; Miscellaneous; Myocardial infarction; Myocardial Infarction - rehabilitation; Myocarditis. Cardiomyopathies; Quality of Life; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Randomized Controlled Trials as Topic; Referral and Consultation - economics
• ISSN: 0167-5273; 1874-1754
• DOI: 10.1016/j.ijcard.2006.07.218

Abstract Background Home-based cardiac rehabilitation offers an alternative to traditional, hospital-based cardiac rehabilitation. Aim To compare the cost effectiveness of home-based cardiac rehabilitation and hospital-based cardiac rehabilitation. Methods 104 patients with an uncomplicated acute myocardial infarction and without major comorbidity were randomized to receive home-based rehabilitation ( n = 60) i.e. nurse facilitated, self-help package of 6 weeks' duration (the Heart Manual) or hospital-based rehabilitation for 8–10 weeks ( n = 44). Complete economic data were available in 80 patients (48 who received home-based rehabilitation and 32 who received hospital-based rehabilitation). Healthcare costs, patient costs, and quality of life (EQ-5D4.13) were assessed over the 9 months of the study. Results The cost of running the home-based rehabilitation programme was slightly lower than that of the hospital-based programme (mean (95% confidence interval) difference − £30 (− £45 to − £12) [− €44, − €67 to − €18] per patient. The cost difference was largely the result of reduced personnel costs. Over the 9 months of the study, no significant difference was seen between the two groups in overall healthcare costs (£78, − £1102 to £1191 [− €115, − €1631 to − €1763] per patient) or quality adjusted life-years (− 0.06 (− 0.15 to 0.02)). The lack of significant difference between home-based rehabilitation and hospital-based rehabilitation did not alter when different costs and different methods of analysis were used. Conclusions The health gain and total healthcare costs of the present hospital-based and home-based cardiac rehabilitation programmes for patients after myocardial infarction appear to be similar. These initial results require affirmation by further economic evaluations of cardiac rehabilitation in different settings.